Abcam plc ABCM
$ 23.99
0.0%
Annual report 2022
added 11-16-2024
Country |
Britain |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Alan Thomas Hirzel BS, MS, MBA |
Employees in the company |
1 492 |
Shares |
- |
Market Cap[1] |
$ 4.9 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.